Axel Hamann

Axel Hamann is an accomplished finance professional with extensive experience in mergers and acquisitions, internal audit, and risk management. Currently serving as Head of M&A and Head of Internal Audit & Risk Management at Bayer, Axel has previously held roles such as CFO of Bayer Pharmaceuticals, Program Lead for Bayer 2022, and Head of Bayer Business Consulting. Additionally, Axel has contributed to the German-Turkish Chamber of Commerce as a Board Member and gained legal expertise as a Senior Associate at Hengeler Mueller and as an International Trainee at Shearman & Sterling LLP. Axel's academic credentials include an Executive MBA in Finance from Northwestern University's Kellogg School of Management and a program at Harvard Business School.